Pfizer to invest €145m in plant

Biopharmaceutical company Pfizer is to invest €145 million in Grange Castle manufacturing facility in Clondalkin, Co

Biopharmaceutical company Pfizer is to invest €145 million in Grange Castle manufacturing facility in Clondalkin, Co. Dublin, Taoiseach Enda Kenny said today.

Pfizer set up in Ireland in 1969 and employs almost 4,300 people in eight locations in Cork, Dublin, Kildare and Limerick.

Making today's announcement, Mr Kenny said the investment was very welcome news.

"Pfizer has made a tremendous contribution to Ireland's life sciences industry since it first established here in 1969 and this investment is a further demonstration of the company's continuous commitment to Ireland."

The investment will enable Pfizer to introduce two new processing suites to the site and expand current production and product testing capabilities.

Pfizer’s Grange Castle facility is one of the largest biotech manufacturing sites in the world and currently produces two of the company’s blockbuster medicines – Enbrel and Prevenar 13. The facility employs approximately 1100 full time staff.